Publications for William Stevenson
Publications for William Stevenson
2016
Gifford, G., Gill, A., Stevenson, W. (2016).
Molecular subtyping of diffuse large B-cell
lymphoma: update on biology, diagnosis and
emerging platforms for practising pathologists.
Pathology, 418(1), 5-16. <a
href="http://dx.doi.org/10.1016/j.pathol.2015.11.
017">[More Information]</a>
Andrici, J., Farzin, M., Clarkson, A., Sioson, L.,
Sheen, A., Watson, N., Toon, C., Koleth, M.,
Stevenson, W., Gill, A. (2016). Mutation specific
immunohistochemistry is highly specific for the
presence of calreticulin mutations in
myeloproliferative neoplasms. Pathology, 48(4),
319-324. <a
href="http://dx.doi.org/10.1016/j.pathol.2016.03.
002">[More Information]</a>
2015
Gifford, G., Wong, K., Kerridge, I., Stevenson,
W., Arthur, C., Fay, K., Greenwood, M. (2015).
Addition of low dose total body irradiation to
fludarabine melphalan reduced intensity
conditioning is feasible, tolerable, and may
improve outcomes in patients with high-risk
acute myeloid leukaemia and other high risk
myeloid malignancies. American Journal Of
Hematology, 90(5), e97-e100. <a
href="http://dx.doi.org/10.1002/ajh.23974">[Mo
re Information]</a>
Lynagh, M., Clinton-Mcharg, T., Hall, A.,
Sanson-Fisher, R., Stevenson, W., Tiley, C.,
Bisquera, A. (2015). Are Australian clinicians
monitoring medication adherence in
hematological cancer survivors? Two
cross-sectional studies. Experimental
Hematology & Oncology, 4, 1-8. <a
href="http://dx.doi.org/10.1186/s40164-015-001
1-4">[More Information]</a>
Wei, A., Tan, P., Perruzza, S., Govindaraj, C.,
Fleming, S., Macmanus, J., Avery, S., Patil, S.,
Stevenson, W., Plebanski, M., et al (2015).
Maintenance lenalidomide in combination with
5-azacitidine as post-remission therapy for acute
myeloid leukaemia. British Journal of
Haematology, 169(2), 199-210. <a
href="http://dx.doi.org/10.1111/bjh.13281">[Mo
re Information]</a>
Stevenson, W., Rabbolini, D., Beutler, L., Chen,
Q., Gabrielli, S., Mackay, J., Brighton, T., Ward,
C., Morel-Kopp, M. (2015). Paris-Trousseau
thrombocytopenia is phenocopied by the
autosomal recessive inheritance of a
DNA-binding domain mutation in FLI1. Blood,
126(17), 2027-2030. <a
href="http://dx.doi.org/10.1182/blood-2015-06-6
50887">[More Information]</a>
Stevenson, W., Morel-Kopp, M., Ward, C.
(2015). Platelets are not all gray in GFI1B
disease. Clinical Genetics, 87(3), 299-299. <a
href="http://dx.doi.org/10.1111/cge.12424">[Mo
re Information]</a>
Ho, J., Marlton, P., Tam, C., Stevenson, W.,
Ritchie, D., Bird, R., Dunlop, L., Durrant, S.,
Ross, D. (2015). Practical management of
myelofibrosis with ruxolitinib. Internal Medicine
Journal, 45(12), 1221-1230. <a
href="http://dx.doi.org/10.1111/imj.12921">[Mo
re Information]</a>
Bryant, J., Sanson-Fisher, R., Stevenson, W.,
Smits, R., Henskens, F., Wei, A., Tzelepis, F.,
D'Este, C., Paul, C., Carey, M. (2015). Protocol
of a multi-centre randomised controlled trial of a
web-based information intervention with
nurse-delivered telephone support for
haematological cancer patients and their support
persons. BMC Cancer, 15(1), 1-13. <a
href="http://dx.doi.org/10.1186/s12885-015-131
4-x">[More Information]</a>
Estecio, M., Madipoti, S., Bueso-Ramos, C.,
DiNardo, C., Yang, H., Wei, Y., Kondo, K.,
Fang, Z., Stevenson, W., Chang, K., et al (2015).
RUNX3 promoter hypermethylation is frequent
in leukaemia cell lines and associated with acute
myeloid leukaemia inv(16) subtype. British
Journal of Haematology, 169(3), 344-351. <a
href="http://dx.doi.org/10.1111/bjh.13299">[Mo
re Information]</a>
Crassini, K., Stevenson, W., Mulligan, S., Best,
O. (2015). The MEK1/2 inhibitor, MEKi-1,
induces cell death in chronic lymphocytic
leukemia cells under conditions that mimic the
tumor microenvironment and is synergistic with
fludarabine. Leukemia & Lymphoma, 56(12),
3407-3417. <a
href="http://dx.doi.org/10.3109/10428194.2015.
1032963">[More Information]</a>
2014
Stevenson, W., Best, O., Przybylla, A., Chen, Q.,
Singh, N., Koleth, M., Pierce, S., Kennedy, T.,
Tong, W., Kuang, S., et al (2014). DNA
methylation of membrane-bound tyrosine
phosphatase genes in acute lymphoblastic
leukemia. Leukemia, 28(4), 787-793. <a
href="http://dx.doi.org/10.1038/leu.2013.270">[
More Information]</a>
Rabbolini, D., Morel-Kopp, M., Stevenson, W.,
Ward, C. (2014). Inherited
Macrothrombocytopenias. Seminars in
Thrombosis and Hemostasis, 40(7), 774-784. <a
href="http://dx.doi.org/10.1055/s-0034-1387922
">[More Information]</a>
Smits, R., Bryant, J., Sanson-Fisher, R., Tzelepis,
F., Henskens, F., Paul, C., Stevenson, W. (2014).
Publications for William Stevenson
Tailored and Integrated Web-Based Tools for
Improving Psychosocial Outcomes of Cancer
Patients: The DoTTI Development Framework.
Journal of Medical Internet Research, 16(3),
1-17. <a
href="http://dx.doi.org/10.2196/jmir.2849">[Mor
e Information]</a>
2013
Stevenson, W., Morel-Kopp, M., Chen, Q.,
Liang, H., Bromhead, C., Wright, S., Turakulov,
R., Ng, A., Roberts, A., Bahlo, M., Ward, C.
(2013). GFI1B mutation causes a bleeding
disorder with abnormal platelet function. Journal
of Thrombosis and Haemostasis, 11(11),
2039-2047. <a
href="http://dx.doi.org/10.1111/jth.12368">[Mor
e Information]</a>
Freeman, J., Crassini, K., Best, G., Forsyth, C.,
MacKinlay, N., Han, P., Stevenson, W.,
Mulligan, S. (2013). Immunoglobulin G subclass
deficiency and infection risk in 150 patients with
chronic lymphocytic leukemia. Leukemia &
Lymphoma, 54(1), 99-104. <a
href="http://dx.doi.org/10.3109/10428194.2012.
706285">[More Information]</a>
Singh, N., Morris, C., Koleth, M., Wong, K.,
Ward, C., Stevenson, W. (2013). Polyploidy in
myelofibrosis: analysis by cytogenetic and SNP
array indicates association with advancing
disease. Molecular Cytogenetics, 6(1), 1-12. <a
href="http://dx.doi.org/10.1186/1755-8166-6-59"
>[More Information]</a>
2012
Hain, S., Khan, S., Stevenson, W. (2012).
18F-FDG PET to identify soft tissue disease in
multiple myeloma. European Journal of Nuclear
Medicine and Molecular Imaging, 39(3),
553-554. <a
href="http://dx.doi.org/10.1007/s00259-011-195
7-z">[More Information]</a>
2010
Dayyani, F., Conley, A., Strom, S., Stevenson,
W., Cortes, J., Borthakur, G., Faderl, S., O'Brien,
S., Pierce, S., Kantarjian, H., et al (2010). Cause
of death in patients with lower-risk
myelodysplastic syndrome. Cancer, 116(9),
2174-2179. <a
href="http://dx.doi.org/10.1002/cncr.24984">[M
ore Information]</a>
Stevenson, W., Hyland, C., Zhang, J., Morgan,
P., Wilson, T., Gill, A., Hilton, A., Viney, E.,
Bahlo, M., Masters, S., et al (2010). Deficiency
of 5-hydroxyisourate hydrolase causes
hepatomegaly and hepatocellular carcinoma in
mice. Proceedings of the National Academy of
Sciences of the United States of America (PNAS),
107(38), 16625-16630. <a
href="http://dx.doi.org/10.1073/pnas.101039010
7">[More Information]</a>
Tong, W., Wei, Y., Stevenson, W., Kuang, S.,
Fang, Z., Zhang, M., Arts, J., Garcia-Manero, G.
(2010). Preclinical antileukemia activity of
JNJ-26481585, a potent second-generation
histone deacetylase inhibitor. Leukemia
Research: clinical and laboratory studies, 34(2),
221-228. <a
href="http://dx.doi.org/10.1016/j.leukres.2009.07
.024">[More Information]</a>
2005
Stevenson, W., Nankivell (Nankievell), B.,
Hertzberg, M. (2005). Nephrotic syndrome after
stem cell transplantation. Clinical
Transplantation, 19(1), 141-144. <a
href="http://www.ncbi.nlm.nih.gov/entrez/query.
fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract
&list_uids=15659148">[More Information]</a>